Stabilization of gap/tight junctions to ameliorate brain death induced endothelial cell injury
Stabilization of gap/tight junctions to ameliorate brain death induced endothelial cell injury
批准号:
9141772
负责人:
Gautam Sudhir Ghatnekar
金额:
$22.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-04 至 2017-07-31
关键词:
AcuteAffectAllogenicAnimalsBiodistributionBiological AssayBiological PreservationBlood VesselsBrain DeathCell Adhesion MoleculesCellsCellular StressCicatrixClinicalClinical DataCoagulation ProcessCoculture TechniquesCommunicationCryopreservationDataEndothelial CellsEnzyme-Linked Immunosorbent AssayEventFibroblastsFlow CytometryGap JunctionsGoalsGraft RejectionGrantHalf-LifeHealedHealthHeartHeart DiseasesHeart InjuriesHeart TransplantationImmuneImmunosuppressionInfiltrationInflammationInflammatory ResponseInjuryIntercellular JunctionsIschemiaKidneyLeadLeukocytesLiverLiving DonorsLungMeasurementMeasuresMetabolicMigration AssayModelingMusOrganOrgan DonationsOrgan DonorOrgan PreservationOrgan Preservation SolutionsOrgan TransplantationOrgan ViabilityOutcomePeptidesPeripheralPermeabilityPharmacotherapyPhasePhysiologicalPlayReperfusion InjuryReperfusion TherapyResearchResistanceRodentSafetySmall Business Innovation Research GrantSourceStagingSurvival RateT-LymphocyteTestingTherapeuticThrombosisTight JunctionsTimeTransplantationTreatment EfficacyUp-Regulationadaptive immunitybasecell injurychronic woundclinically relevantcytokineefficacy testingendothelial dysfunctiongraft failurehealingimmunogenicityimplantationimprovedimproved outcomein vitro Modelin vivomigrationnovelnovel strategiesphase 1 studypreclinical studypreventpublic health relevanceregenerativeresponsesuccesswound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Transplantation is a widely accepted and highly successful therapy for end-stage heart disease. While success rates and survival have risen steadily since its inception almost 50 years ago, due largely to improved immunosuppression regimes, there is a growing appreciate that factors associated with brain death, organ donation, procurement and storage, prior to implantation greatly effect outcomes post transplantation. Clinical data has demonstrated that recipients of hearts from living donors have significantly improved outcomes as compared to those from cadaveric sources. These data suggest that insults to the donor organ induced by brain death, and cold storage, predispose to poorer post transplantation outcomes. These injurious events are thought to initiate organ injury, endothelial dysfunction, and inflammation that are further exacerbated upon implantation and reperfusion, and that primes the donor organ for alloimmune recognition. Therefore strategies to minimize or switch off these injurious events are likely to improve graft outcomes. Cold preservation has greatly facilitated the use of cadaveric hearts for transplantation but, clearly, damage occurs prior to storage from brain death, and during both the preservation episode and the reperfusion phase. While metabolic additives have been incorporated into preservation solutions to prolong storage times and improve organ viability no additives have been incorporated into the preservation solutions to minimize endothelial injury/activation. We hypothesize that brain death, cold preservation, and ischemia reperfusion injury induces cell junction damage, which leads to inflammation, heart damage, and endothelial dysfunction upon reperfusion, and that inclusion of a novel gap and tight junction stabilizing peptide, ACT1, would preserve cell junctions during cold preservation and reduce graft damage and immunogenicity upon reperfusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving marginal allograft outcomes through cell junction stabilization in transplantation
-
批准号:10018537
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Novel small molecule HSP90 inhibitor for the management of atopic dermatitis
-
批准号:10016726
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2020
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Evaluation of a Connexin-based Peptide for the Treatment of Age-Related Macular Degeneration
-
批准号:9346869
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Development of a novel connexin-based peptide for the treatment of corneal injury
-
批准号:8198936
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2012
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Evaluation of a novel connexin-based peptide for the treatment of diabetic wounds
-
批准号:7405169
-
项目类别:
-
资助金额:$14.12万
-
财政年份:2007
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
-
批准号:9100741
-
项目类别:
-
资助金额:$99.73万
-
财政年份:2007
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Evaluation of a Novel Connexin-Based Peptide for the Treatment of Diabetic Wounds
-
批准号:9202629
-
项目类别:
-
资助金额:$85.28万
-
财政年份:2007
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
-
批准号:8046461
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2007
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
-
批准号:8285078
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2007
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
-
批准号:7801887
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2007
-
负责人:Gautam Sudhir Ghatnekar
-
依托单位:
海外基金